Semax
Semax (ACTH 4-10 Analog)
A brain-building nootropic that enhances focus, memory, and mental clarity by boosting your brain's own growth factors rather than borrowing energy from stimulants.
Semax is a synthetic peptide based on a fragment of ACTH, a hormone your body naturally produces. Developed in Russia in the 1980s, it has been used as a prescription medication there for decades to treat stroke, traumatic brain injury, cognitive decline, and even optic nerve disorders. The name comes from the Russian for 'seven amino acids,' which is exactly what it is: a chain of seven amino acids designed to enhance brain function. Unlike many cognitive boosters that work by revving up your brain like a stimulant, Semax enhances cognition by increasing your brain's own growth and repair factors.
What makes Semax stand apart from caffeine, Adderall, or other stimulants is its mechanism. Stimulants essentially borrow energy from your brain's reserves and leave you with a crash. Semax instead increases BDNF (brain-derived neurotrophic factor), which is like fertilizer for your brain cells. It helps neurons grow stronger, form new connections, and work more efficiently. This means the cognitive benefits come from actually building up your brain's capacity rather than depleting it. In healthy people, this translates to sharper focus, better memory, and clearer thinking. In people recovering from stroke or brain injury, it accelerates healing.
Semax is listed on Russia's List of Vital and Essential Drugs and is administered as a nasal spray in Russian clinical practice. It remains a research compound without FDA approval in the United States. For people seeking sustainable cognitive enhancement without the roller-coaster of stimulants, Semax offers a fundamentally different and more brain-supportive approach.
How It Works
To understand Semax, imagine your brain as a garden. BDNF (brain-derived neurotrophic factor) is the fertilizer that helps everything grow: it keeps existing brain cells healthy, encourages new ones to sprout, and strengthens the connections between them. Higher BDNF levels are associated with better learning, stronger memory, and more flexible thinking. Research shows that a single dose of Semax can increase BDNF protein levels by about 1.4 times and the genetic instructions for making BDNF (called mRNA) by up to 3 times in the hippocampus, which is your brain's memory center. It also boosts the activity of TrkB receptors, which are how BDNF delivers its growth signals inside neurons.
Beyond BDNF, Semax works on several other brain systems simultaneously. It increases serotonin metabolites by about 25% in the striatum (a brain region involved in motivation and reward), which contributes to mood stability. It modulates dopamine release, particularly when combined with stimulants, enhancing focus and drive. And in stroke models, genome-wide analysis revealed that Semax affects 96 different genes within just three hours, with more than half related to immune response and blood vessel function. This broad genetic influence helps explain how Semax protects brain tissue during injury.
The practical result of all this is enhanced focus, improved memory, better stress resilience, and protection against neurological damage. Think of it as the difference between flooring the gas pedal (stimulants) versus upgrading your engine (Semax). Stimulants deplete neurotransmitters and lead to crashes. Semax builds up your brain's actual capacity through neurotrophic support. The cognitive effects tend to build over several days of use and feel like a 'clean' sharpening of mental performance rather than the buzzy energy of caffeine.
Potential Benefits
Cognitive Enhancement
The primary benefit for healthy users is sharper mental performance. Research shows enhanced learning, better memory formation, and improved attention. Users commonly report heightened alertness, better verbal fluency, and stronger working memory. These effects come from BDNF upregulation and neurotransmitter modulation, not from stimulation, so there is no crash or depletion afterward.
Neuroprotection
Semax protects brain cells from damage caused by oxidative stress, low oxygen, and inflammation. In stroke models, it limits cell death and preserves brain function. This makes it valuable both for recovery from neurological injury and for long-term brain health maintenance as you age.
Stroke Recovery Support
The strongest clinical evidence for Semax comes from stroke rehabilitation. Russian studies show that treatment increases BDNF plasma levels, accelerates functional recovery, and improves motor performance. Effects are enhanced when combined with early rehabilitation, making it a powerful complement to physical therapy.
Mood and Stress Resilience
Through its effects on serotonin and dopamine, Semax provides mood-stabilizing benefits. Users report improved emotional stability and better ability to maintain cognitive performance under pressure. This is not the same as anti-anxiety effects, but rather a steadiness that keeps you performing well when stressed.
Optic Nerve Support
In Russian clinical practice, Semax is prescribed for optic nerve disorders. Studies show visual field expansion in 80% of treated eyes, with improvements in color vision and reduction of blind spots. The mechanism involves BDNF-mediated neuroprotection of the optic nerve.
Sustainable Enhancement
Unlike stimulants that borrow energy and lead to crashes, Semax builds your brain's actual capacity through neurotrophic support. The benefits accumulate over days of use, and cognitive improvements can persist even after stopping the peptide due to lasting structural changes in neural connections.
What the Research Shows
The foundational study on Semax's brain-building mechanism was published by Dolotov and colleagues in Brain Research (2006). They gave rats a single intranasal dose and found BDNF protein levels increased by 1.4-fold and BDNF mRNA expression increased by up to 3-fold in the hippocampus. TrkB receptor activation rose 1.6-fold. These are not small numbers: they represent a significant ramp-up in the brain's growth and repair machinery. The treated animals also showed improved learning in behavioral tests, directly linking the molecular changes to real cognitive enhancement.
For stroke recovery, the strongest evidence comes from a clinical study by Gusev and colleagues (2018) involving 110 stroke patients. The standard protocol was 6,000 mcg per day for 10 days, repeated after a 20-day break. Results showed that Semax increased BDNF levels in patients' blood regardless of when rehabilitation started. Patients with higher BDNF levels scored better on the Barthel index (a measure of functional independence) and showed improved motor performance. A separate genome-wide study by Medvedeva and colleagues (2014, BMC Genomics) found Semax affected 96 genes in stroke models, with over half related to immune response and blood vessel function, explaining the neuroprotective effects.
Semax also has proven applications beyond cognition and stroke. In optic nerve studies, clinical trials in patients with glaucomatous optic neuropathy showed visual field expansion averaging 57.5 degrees in 80% of treated eyes after 30 days, along with improved color perception and reduced blind spots. Research by Eremin and colleagues (2005, Neurochemical Research) confirmed that Semax activates both dopamine and serotonin systems, with serotonin metabolites increasing approximately 25% in the striatum. These converging lines of evidence paint a picture of a compound that broadly supports brain health through multiple mechanisms.
What to Know
Nasal irritation is the most frequently reported side effect when used intranasally, along with a temporary yellowish tinge to nasal mucosa that resolves on its own.
Occasional mild headache and uncommon dizziness have been reported, both generally resolving quickly without intervention.
Sleep disturbance may occur if taken too late in the day, and some users experience overstimulation at higher doses. Morning or early afternoon use is recommended.
Diabetics should monitor blood glucose levels carefully, as Semax may affect glucose regulation. Individuals with a history of mania or bipolar disorder should use caution since BDNF affects mood pathways.
People with active cancer should avoid Semax because BDNF can theoretically support tumor growth. Those with a history of seizures should also exercise caution as neurotrophin modulation may affect seizure threshold.
Effects on pregnancy and breastfeeding are unknown and unstudied. Continuous long-term use is not recommended due to the risk of BDNF receptor downregulation; cycling protocols should be followed.
Research References
Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus
Dolotov OV, Karpenko EA, Inozemtseva LS, et al. · Brain Research · 2006
Demonstrated that a single intranasal Semax dose increased BDNF protein by 1.4-fold, BDNF mRNA by 3-fold, and TrkB phosphorylation by 1.6-fold in the hippocampus, with treated animals showing enhanced conditioned avoidance reactions.
View StudyThe efficacy of semax in the treatment of patients at different stages of ischemic stroke
Gusev EI, Martynov MYu, Kostenko EV, et al. · Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova · 2018
Clinical study of 110 stroke patients found Semax (6,000 mcg/day for 10 days) increased BDNF plasma levels and correlated with better Barthel scores for functional independence and improved motor performance.
View StudyThe peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis
Medvedeva EV, Dmitrieva VG, Povarova OV, et al. · BMC Genomics · 2014
Genome-wide analysis showing Semax affected 96 genes at 3 hours post-administration in stroke models, with over half related to immune response and vascular function, explaining broad neuroprotective mechanisms.
View StudySemax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents
Eremin KO, Kudrin VS, Saransaari P, et al. · Neurochemical Research · 2005
Showed Semax activates both dopaminergic and serotonergic systems, increasing serotonin metabolites by approximately 25% in the striatum and potentiating dopamine release when combined with amphetamine.
View StudySemax as a universal drug for therapy and research
Koroleva SV, Myasoedov NF. · Biology Bulletin · 2018
Comprehensive review covering Semax's clinical applications, mechanisms of action, and decades of use as a prescribed medication in Russia for stroke, cognitive decline, and optic nerve disorders.
View Study